Filter News
Area of Research
- (-) National Security (18)
- (-) Nuclear Science and Technology (4)
- Advanced Manufacturing (2)
- Biological Systems (1)
- Biology and Environment (32)
- Clean Energy (75)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (3)
- Computer Science (4)
- Fusion and Fission (1)
- Fusion Energy (1)
- Isotopes (2)
- Materials (43)
- Materials for Computing (5)
- Mathematics (1)
- Neutron Science (23)
- Quantum information Science (2)
- Supercomputing (40)
- Transportation Systems (2)
News Type
News Topics
- (-) Bioenergy (2)
- (-) Biomedical (3)
- (-) Cybersecurity (10)
- (-) Machine Learning (4)
- (-) Physics (2)
- (-) Summit (1)
- (-) Transportation (2)
- 3-D Printing/Advanced Manufacturing (3)
- Advanced Reactors (7)
- Artificial Intelligence (6)
- Big Data (2)
- Biology (2)
- Chemical Sciences (2)
- Climate Change (1)
- Computer Science (11)
- Coronavirus (1)
- Decarbonization (1)
- Energy Storage (2)
- Environment (2)
- Exascale Computing (1)
- Frontier (1)
- Fusion (3)
- Grid (3)
- High-Performance Computing (1)
- Isotopes (3)
- Materials (1)
- Materials Science (2)
- Molten Salt (3)
- National Security (11)
- Neutron Science (5)
- Nuclear Energy (19)
- Partnerships (4)
- Security (6)
- Space Exploration (4)
- Sustainable Energy (3)
- Transformational Challenge Reactor (1)
Media Contacts
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.